MicroRNA-485-5p inhibits glioblastoma progression by suppressing E2F transcription factor 1 under cisplatin treatment

Cisplatin (CDDP) has been widely used for glioblastoma treatment. miR-485-5p and E2F transcription factor 1 (E2F1) dysfunction has been reported in glioblastoma. Nonetheless, whether CDDP affects glioblastoma progression via the miR-485-5p-E2F1 axis requires investigation. The expression of miR-485-...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Conggang, Ma, Lan, Duan, Faliang, Li, Ruixue, Zhang, Yanguo, Wang, Yuan, Luo, Ming, He, Zhuqiang, Luo, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806419/
https://www.ncbi.nlm.nih.gov/pubmed/34726120
http://dx.doi.org/10.1080/21655979.2021.1982269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806419/
https://www.ncbi.nlm.nih.gov/pubmed/34726120
http://dx.doi.org/10.1080/21655979.2021.1982269

Ejemplares similares